Compare Dover Corp (DOV) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dover Corp vs Twist Bioscience Corp — how do they compare? Dover Corp trades at $208.79 (market cap $28.07B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Dover Corp is far larger — about 3.6× Twist Bioscience Corp's market cap, and Dover Corp pays a 1.01% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| DOV | TWST | |
|---|---|---|
Market Cap | $28.07B | $7.72B |
Sector | Industrials | Health |
52-Week High | $233.31 | $124.88 |
52-Week Low | $161.16 | $24.16 |
Enterprise Value | $29.58B | $7.65B |
Dividend Yield | 1.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
